fumigatus can be selected for in the presence of gliotoxin, without the use of conventional selection markers, and that transformation of A
Evening dosing produces more consistent results across the full cycle because GH secretion patterns remain stable regardless of estrogen or progesterone levels
The ASCO 2026 data does not support starting a GLP-1 medication in someone at a healthy weight for cancer prevention alone
Other biological targets: biological peptides, neuroinflammation and the intestinal flora The neuropeptide theory of autism is backed up by evidence from animal research
References: A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
16 (1), 4358 (2018) C.O
